Cubist Systematic Strategies LLC trimmed its holdings in shares of Genworth Financial, Inc. (NYSE:GNW - Free Report) by 37.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,125,931 shares of the financial services provider's stock after selling 682,993 shares during the period. Cubist Systematic Strategies LLC owned 0.26% of Genworth Financial worth $7,870,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Donald Smith & CO. Inc. raised its stake in Genworth Financial by 3.7% during the fourth quarter. Donald Smith & CO. Inc. now owns 25,949,469 shares of the financial services provider's stock worth $181,387,000 after acquiring an additional 934,175 shares during the period. American Century Companies Inc. raised its position in shares of Genworth Financial by 8.8% during the 4th quarter. American Century Companies Inc. now owns 7,220,342 shares of the financial services provider's stock worth $50,470,000 after purchasing an additional 582,147 shares during the period. Northern Trust Corp lifted its holdings in shares of Genworth Financial by 18.1% in the 4th quarter. Northern Trust Corp now owns 6,025,178 shares of the financial services provider's stock worth $42,116,000 after purchasing an additional 922,126 shares during the last quarter. Prudential Financial Inc. lifted its holdings in shares of Genworth Financial by 70.2% in the 4th quarter. Prudential Financial Inc. now owns 5,567,978 shares of the financial services provider's stock worth $38,920,000 after purchasing an additional 2,296,538 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Genworth Financial by 1.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 5,195,012 shares of the financial services provider's stock valued at $36,313,000 after purchasing an additional 99,120 shares during the period. 81.85% of the stock is currently owned by institutional investors.
Genworth Financial Stock Performance
GNW stock traded up $0.03 during mid-day trading on Friday, reaching $7.05. The company had a trading volume of 4,644,593 shares, compared to its average volume of 3,829,249. Genworth Financial, Inc. has a one year low of $5.87 and a one year high of $7.90. The stock has a market capitalization of $2.93 billion, a P/E ratio of 10.37 and a beta of 0.99. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.16. The stock's 50-day simple moving average is $6.77 and its two-hundred day simple moving average is $7.01.
Genworth Financial (NYSE:GNW - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.09). Genworth Financial had a net margin of 4.10% and a return on equity of 2.96%. The firm had revenue of $1.76 billion during the quarter.
Genworth Financial Company Profile
(
Free Report)
Genworth Financial, Inc, together with its subsidiaries, provides mortgage and long-term care insurance products in the United States and internationally. It operates in three segments: Enact, Long-Term Care Insurance, and Life and Annuities. The Enact segment offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products.
Recommended Stories

Before you consider Genworth Financial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genworth Financial wasn't on the list.
While Genworth Financial currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.